Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor.
about
Circulating microRNA-194 regulates human melanoma cells via PI3K/AKT/FoxO3a and p53/p21 signaling pathway.NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib.Anticancer activity of 23,24-dihydrocucurbitacin B against the HeLa human cervical cell line is due to apoptosis and G2/M cell cycle arrest.2-Methyl 2-butanol suppresses human retinoblastoma cells through cell cycle arrest and autophagy.
P2860
Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting the PI3K/AKT/mTOR pa ...... istance to the BRAF inhibitor.
@en
type
label
Targeting the PI3K/AKT/mTOR pa ...... istance to the BRAF inhibitor.
@en
prefLabel
Targeting the PI3K/AKT/mTOR pa ...... istance to the BRAF inhibitor.
@en
P2093
P50
P356
P1476
Targeting the PI3K/AKT/mTOR pa ...... istance to the BRAF inhibitor.
@en
P2093
Elisabetta Caprini
Ester Alvino
Gian Carlo Antonini Cappellini
Lauretta Levati
Simona Caporali
Stefania D'Atri
P304
P356
10.3892/IJO.2016.3594
P577
2016-06-30T00:00:00Z